-
1دورية أكاديمية
المؤلفون: Hideo Harigae, Hisayuki Yokoyama, Junichi Kameoka, Kenichi Ishizawa, Koichi Miyamura, Minami Yamada, Takeshi Sasaki, Tohru Fujiwara, Yasuo Tomiya
المصدر: The Tohoku Journal of Experimental Medicine. 2004, 204(1):79
-
2دورية أكاديمية
المؤلفون: Chiaki Kato, Hideo Harigae, Izumi Ishikawa, Junichi Kameoka, Kenichi Ishizawa, Koichi Miyamura, Minami Yamada, Takeshi Sasaki, Tomohiro Sugawara, Yasuo Tomiya
المصدر: The Tohoku Journal of Experimental Medicine. 2006, 210(4):355
-
3
المؤلفون: Tomohiro Sugawara, Hideo Harigae, Koichi Miyamura, Takeshi Sasaki, Junichi Kameoka, Chiaki Kato, Kenichi Ishizawa, Minami Yamada, Yasuo Tomiya, Izumi Ishikawa
المصدر: The Tohoku journal of experimental medicine. 210(4)
مصطلحات موضوعية: Oncology, Adult, Male, medicine.medical_specialty, Fusion Proteins, bcr-abl, Chromosomal translocation, Antineoplastic Agents, Pharmacology, Polymerase Chain Reaction, General Biochemistry, Genetics and Molecular Biology, Drug Administration Schedule, Patient Care Planning, Piperazines, Myelogenous, hemic and lymphatic diseases, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, medicine, Biomarkers, Tumor, Humans, neoplasms, Aged, Dose-Response Relationship, Drug, business.industry, Remission Induction, Imatinib, General Medicine, Middle Aged, medicine.disease, Leukemia, Imatinib mesylate, Real-time polymerase chain reaction, Pyrimidines, Treatment Outcome, Benzamides, Imatinib Mesylate, Female, Neoplasm Recurrence, Local, business, Tyrosine kinase, Chronic myelogenous leukemia, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c29398b03d1b312e3df0c77d5cb23e79Test
https://pubmed.ncbi.nlm.nih.gov/17146202Test -
4
المؤلفون: Junichi Kameoka, Minami Yamada, Kenichi Ishizawa, Tohru Fujiwara, Hisayuki Yokoyama, Yasuo Tomiya, Takeshi Sasaki, Hideo Harigae, Koichi Miyamura
المصدر: The Tohoku journal of experimental medicine. 204(1)
مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, medicine.medical_treatment, Antineoplastic Agents, Hematopoietic stem cell transplantation, Gastroenterology, General Biochemistry, Genetics and Molecular Biology, Piperazines, Myelogenous, hemic and lymphatic diseases, Internal medicine, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, medicine, Humans, Transplantation, Homologous, Enzyme Inhibitors, business.industry, Hematopoietic Stem Cell Transplantation, Myeloid leukemia, Imatinib, General Medicine, Middle Aged, medicine.disease, Transplantation, Leukemia, Imatinib mesylate, Graft-versus-host disease, Pyrimidines, Treatment Outcome, Immunology, Benzamides, Cyclosporine, Imatinib Mesylate, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9887f7db4f7c7b389e1513d838a6e2a0Test
https://pubmed.ncbi.nlm.nih.gov/15329466Test